Stockreport

Alumis to Participate in Upcoming November Investor Conferences

Alumis Inc.  (ALMS) 
PDF SOUTH SAN FRANCISCO, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Alumis Inc. (Nasdaq: ALMS), a late-stage biopharma company developing next-generation targeted therapies [Read more]